SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dukie who wrote (545)4/25/1998 12:05:00 AM
From: John Binford, Jr.  Read Replies (1) of 1754
 
" I just read a research report that makes the following observations about visx and beam. The most recent class action suit filed in California superior court (a court whose laws mimic the federal anti-trust laws) leaves each company liable for in excess of $90 million dollars. The consumer class action is a different law suit with different plantiffs but seeking similar damages. "

Maybe, the class action suit should be expanded to include the doctors. How is it that the doctors charge about the same high fee for the procedure? It must be collusion! Look at the damage done to the innocent public! How could they charge so much for a procedure that only takes a couple of minutes? Certainly an appropriate fee is $250, so the public has been overcharged by $1400 per procedure! And at 200,000 procedures for 1997, the damage to consumers would be $280 million. This is an outrage! Call the FTC and complain!

If the FTC is allowed to set prices, then the doctors are in trouble--just ask doctors with medicare patients! The FTC doesn't have the right to set prices on this elective procedure. Certainly the inventors of this technology have a right to demand whatever royalty they want for the life of their patents. If the fee is too high then people can choose not to have the procedure. Who said Pfizer can charge $10/pill for Viagre? Why doesn't the FTC go after the FDA which dragged their feet on approving both Visx and Summit. The FDA has cost consumers not only money, but the ability to get the procedure before late 1995.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News